Many of your patients are predisposed to hyper-metabolizecertain drugs, which can lead to critical adverse reactions.Manymorewillhypo-metabolizemedicationstothepointthattheyarevirtualplacebos. PGx,orPharmacogenomicsTestingisaneasy,inexpensive,CMSrecommendedwaytodetermineifmedicationisineffectiveorworse,dangerous.PGxAmericaCorp.hasdevelopedasimplifiedprocessthatwilllet your practice access this critical tool without anyinvestment or additional staff burden. You will learn thecritical technologies that are reshaping the future ofdiagnosticstoday.TherapeuticDrugMonitoringwithPGxtestswill greatly increase the scope of bodily systems reviewed inany clinical situation. Our strategies make sure that yourpracticeisadequatelyreimbursedbyemphasizingcomplianceandtransparency.

1) theNURSE ItallbeginswiththenursewhoidentifiesapatientmatchingcriticalCMScriterionasseriouslyatriskofAdverseDrugReaction.

-Numberofmedications.Fourormoreprescribedmedicationscanindicate ahighrisk.

-Natureofmedications.Cardioandvascularmedicationsincludingstatinsorpsychiatricdrugsincludinganti-depressantsarefrequentlyadverse.

Whenbothnumberandnatureofcriterionaremetnursemayproceedtotakebuccalswab,20secondspersideofmouth.Bagandlabelswabs.NotifypractitionerthatTherapeuticMedicationMonitoringEncounterisadvised.Nursemayalsopullswabkitforpractitionertoadminister.

2)theDOCTORThephysicianshouldinitiateaTherapeuticDrugMonitoringEncounterwithpatientduetoconcernswithnumberandnatureofdrugstaken.Askforpatientsperceptionoftheeffectivenessandsuspectedsideeffectsofeachmedication.Chartingshouldbesimplebutspecific.E&Mlevelshouldbeelevatedduetoincreasescopeofbodysystemsreviewed.IndicatethatphysicianinitiatedTherapeuticDrugMonitoringEncounterduetoconcernsofnumberandnatureofmedications,andspecifycardio-vascularorpsychiatricmedicationwithconcern.AnE&Mincreaseof2levelsisonlyindicatedinacasewherethepatientmaybeexperiencingacriticaladversereaction.Neverindicatethatatestisbeingperformedto“ruleout”acause,butrathertoproveapresumption.

3)theBILLERWhetherthedoctororatranscriptionistchartsthevisititisvitallyimportanttonotetheTherapeuticMedicationMonitoringEncounteralongwiththeconcernsduetonumberandnatureofmedications.Evenifatestisnotdeterminedtobenecessaryafterthereview,thereviewitselfismedicallynecessaryifpatientistaking4ormoreprescriptionmedicationsincludingcardioorpsychdrugs.ThusE&Mcodingshouldreflectthatincreaseinscopeofbodysystemsreview.

-Ifaswabisadministereduseanappropriatelocalfee.-TherapeuticDrugMonitoringEncounter:Z51.81Z79.01forlongtermuseofanti-coagulantsexcludingaspirinOr:ICD-10-CMZ79.899Otherlongterm(current)drugtherapy

4)theLAB In72hoursthelabwillsecurelysendthecomprehensivepharmacogenomicstestresultstothepracticeforphysiciantoreview.Itiscolorcodedtoreadilyidentifyissuesofconcernincludingnecessarydosingchanges.Alaboratorytechnicianwillbewaitingbythephoneforyourcalltoanswerallofyourquestionsandexplaintheresultsinashighadetailasyouwouldliketogo.Ourpeopleareyourpeople.It’slikewearejustdownthehall,anytime,everyday.

Pharmacogenomic testing will be a common tool in the 21stcenturydoctors’bag. After just a couple tests thiswillbeaseamlessandintegralpartofyourpractice.Asmoreandmoretests are available you will stay on the leading edge ofdiagnosticmedicine.PGxAmericawillguideyoualongthewayincorporatingthisdiagnosticmiracleintoyourpractice.Theonlywaytostartisbystarting.Today.Wewillbewithyoueverystepoftheway.ForhelpwithyouraccountpleasecallyourAccountExecutiveArneyBensonat:

1(480)399-2877

2015PGxAMERICACORPvWASHINGTONPAUSA